Related Experiment Video
Updated: Jan 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Antibiotic-Resistant Community-Acquired Bacterial Pneumonia
1Department of Microbiology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong.
Antimicrobial resistance is a growing global threat. Understanding common resistant pathogens in community-acquired respiratory infections can improve antibiotic use and preserve effective treatments.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Antimicrobial resistance (AMR) is a critical global health issue.
- Antibiotics are frequently prescribed for acute respiratory tract infections (ARTIs) in adults.
- Community-acquired pneumonia (CAP) presents a substantial health and economic challenge, exacerbated by aging populations.
Purpose of the Study:
- To update knowledge on prevalent antimicrobial-resistant pathogens in community-acquired respiratory tract infections (CARTIs).
- To assess the prevalence and resistance patterns of these pathogens.
- To inform strategies for enhancing appropriate antibiotic use in healthcare settings.
Main Methods:
- Literature review and data synthesis on antimicrobial resistance in CARTIs.
- Analysis of pathogen prevalence and antimicrobial susceptibility data.
- Epidemiological assessment of resistance trends.
Main Results:
- Identification of key resistant pathogens commonly implicated in CARTIs.
- Quantification of their prevalence and specific resistance profiles.
- Highlighting the need for updated guidelines on antibiotic selection.
Conclusions:
- Updated knowledge on resistant pathogens is crucial for combating AMR.
- Prudent antibiotic prescribing for CARTIs is essential.
- Enhanced understanding can improve treatment outcomes and preserve antibiotic efficacy.
More Related Videos
07:39Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
Published on: April 6, 2021
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Development of Antibiotic Resistance
Pneumonia III: Complications and Assessment
Acute Pyelonephritis II: Diagnostic Studies and Management
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...